For condition: Palmoplantar Pustulosis
Palmoplantar Pustulosis Study (19 – 22 Weeks)
Study Summary
Who Can Participate?
Adults aged 18 years or above
Inclusion Criteria
• Has mild to severe PPP current condition defined by:
• Disease duration of PPP of > 6 months before randomisation.
• PPP-PGA of at least mild severity (PPP-PGA ≥2)
• Palmoplantar Pustulosis Area and Severity Index (PPPASI) ≥ 8
• Has Presence of ≥ 5 well-demarcated fresh pustules (white or yellow pustules) in total across all affected areas
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating palmoplantar pustulosis (9 visits)
• Will receive an investigative topical treatment (study drug)
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• 19 – 22 weeks
For more information about this trial, please visit ClinicalTrials.gov
